Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.15
-
NAV
₹34.58
-
Fund Started
04 Dec 2015
-
Fund Size
₹1229.42 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year
1.61%
-
3 Year
21.87%
-
5 Year
13.38%
-
Equity
99.69%
-
Cash
0.31%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.34% |
Abbott India Ltd. | 5.89% |
Divi's Laboratories Ltd. | 5.83% |
Healthcare Global Enterprises Ltd. | 5.39% |
Max Healthcare Institute Ltd. | 5.14% |
Cipla Ltd. | 5.10% |
Apollo Hospitals Enterprise Ltd. | 4.25% |
Rainbow Children's Medicare Ltd. | 4.23% |
Mankind Pharma Ltd. | 3.57% |
Bayer CropScience Ltd. | 3.51% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
